Improving cancer research and training for diverse communities
Planning & Evaluation
This study is all about improving cancer treatment and research by teaming up two great institutions to support and train new researchers from diverse backgrounds, making sure that everyone in Southern California has better access to clinical trials and care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Riverside NIH-funded |
| Lab location | 1 site (Riverside, United States) |
| Project ID | NIH-10933480 on NIH RePORTER |
What this research studies
This research focuses on enhancing cancer research and drug development by building partnerships between the University of California, Riverside and the City of Hope Comprehensive Cancer Center. It aims to monitor and evaluate the progress of these partnerships in achieving their goals of capacity-building, education, and training. The initiative emphasizes diversity and equity in cancer therapeutics and aims to mentor early-stage investigators from diverse backgrounds. By involving various advisory boards, the project seeks to ensure that the needs of Southern California communities are met and that disparities in access to clinical trials are addressed.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals from diverse backgrounds who are affected by cancer and are interested in participating in clinical trials.
Not a fit: Patients who are not affected by cancer or who do not reside in the targeted Southern California communities may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more equitable access to cancer treatments and improved outcomes for diverse patient populations.
How similar studies have performed: Similar initiatives have shown promise in enhancing diversity and equity in clinical research, indicating a potential for success in this approach.
Where this research is happening
Riverside, United States
- University of California Riverside — Riverside, United States (Active)
Researchers
- Principal investigator: Davis, Kendrick — University of California Riverside
- Study coordinator: Davis, Kendrick
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.